Delivery Order SPE2DB24D2216-SPE2DB25FGPWD
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) valued at $12,491.82 under a firm fixed price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and the performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,953.32 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5mL) on September 25, 2025, with completion targeted for September 26, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Rotarix vaccine oral syringes (1.5ml) with a ceiling value of $3,632.23. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML with a ceiling value of $14,065.80. This firm fixed price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rotarix vaccine oral syringes (1.5 mL) with a ceiling value of $2,214.99. This firm fixed price delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 mL) under a firm fixed price contract valued at $11,884.18. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with a ceiling value of $6,750.09. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a $2,214.99 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rotarix vaccine oral syringes (1.5mL). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPWDDelivery Order
The Defense Logistics Agency awarded a $2,953.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supplying an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This vaccine delivery order aligns with the company's broader role as a prime vendor under the DLA's pharmaceutical support framework, which enables global pharmaceutical supply chain support for Defense Health Agency customers, the U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement and its substantial IDC vehicle position it as a key provider for federal vaccine and pharmaceutical distribution needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/22/25 |